Background: Mild cognitive impairment (MCI) is a condition that carries a substantial risk of dementia. The exact magnitude of that risk is uncertain because of the variations in the definition of MCI ...
Objective Traumatic brain injury (TBI) and rapid eye movement sleep behavioural disorder (RBD) are risk factors for Parkinson’s disease (PD). Dopaminergic abnormalities are often seen after TBI, but ...
Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, and the National Hospital for Neurology and Neurosurgery, London, UK Correspondence to: Professor Ley Sander Department of ...
Department of Neurosurgery, Istituto Nazionale Neurologico C. Besta, Milan, Italy Dr Giovanni Broggi, Department of Neurosurgery, Istituto Nazionale Neurologico C Besta, Via Celoria 11, 20133 Milan, ...
a Secure Care Program, Department of Psychiatry, Taunton State Hospital, Taunton, MA, USA, and Harvard Medical School, Boston, MA, USA, b Departments of Neurology ...
Correspondence to: Dr Graham G Lennox, Department of Neurology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK; email: bl224{at}cam.ac.uk The irritating historical division between neurology and ...
Background For more than 15 years, deep brain stimulation (DBS) has served as a last-resort treatment for severe treatment-resistant obsessive-compulsive disorder (OCD). Methods From 2010 to 2016, 20 ...
Professor JS Duncan, National Society for Epilepsy, National Hospital for Neurology and Neurosurgery, Chalfont St Peter, Gerrards Cross, Bucks SL9 0RJ, UK. Telephone 0044 (0) 1494 601300; fax 0044 (0) ...
Dr Sergio Paradiso, University of Iowa College of Medicine Psychiatry Research, MEB, Iowa City, IA 52241, USA. Telephone 001 319 353 4446; fax 001 319 353 3003; email sergio-paradiso{at}uiowa.edu ...
Correspondence to Dr Sanjib Sinha, Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India; sanjib_sinha2004{at}yahoo.co.in Background High-level ...
Background Synaptosomal-associated protein 25 (SNAP-25) in cerebrospinal fluid (CSF) is an emerging synaptic biomarker for the early diagnosis of Alzheimer’s disease (AD). However, comprehensive ...